PURPOSE: To evaluate the efficacy of nonsurgical treatments for caudate hepatocellular carcinoma (HCC). METHODS: Between January 1994 and February 2001, 25 patients were treated for HCCs with percutaneous ethanol injection (PEI), and/or transcatheter arterial embolization (TAE). PEI was performed for 19 caudate HCCs, combined treatment with PEI and TAE for 4 nodules, and TAE for 2 nodules. RESULTS: During follow-up periods ranging from 3 to 60 months (mean 21.3 months), 18 patients had no local recurrence. Local recurrence was seen in 7 patients, and recurrence in the other segments of the liver in 15 patients. Thirteen patients were alive, ranging from 6 to 60 months, and 12 patients died of multiple HCCs, hepatic failure, or rupture of esophageal varix. The 1-, 2-, 3-, and 5-year survival rates of the 25 patients were 70.6%, 60.2%, 48.1%, and 16.0%, respectively. CONCLUSION: PEI, PEI and TAE, or TAE would be an effective alternative treatment for HCC in the caudate lobe.
PURPOSE: To evaluate the efficacy of nonsurgical treatments for caudate hepatocellular carcinoma (HCC). METHODS: Between January 1994 and February 2001, 25 patients were treated for HCCs with percutaneous ethanol injection (PEI), and/or transcatheter arterial embolization (TAE). PEI was performed for 19 caudate HCCs, combined treatment with PEI and TAE for 4 nodules, and TAE for 2 nodules. RESULTS: During follow-up periods ranging from 3 to 60 months (mean 21.3 months), 18 patients had no local recurrence. Local recurrence was seen in 7 patients, and recurrence in the other segments of the liver in 15 patients. Thirteen patients were alive, ranging from 6 to 60 months, and 12 patients died of multiple HCCs, hepatic failure, or rupture of esophageal varix. The 1-, 2-, 3-, and 5-year survival rates of the 25 patients were 70.6%, 60.2%, 48.1%, and 16.0%, respectively. CONCLUSION:PEI, PEI and TAE, or TAE would be an effective alternative treatment for HCC in the caudate lobe.
Authors: Shu You Peng; Jiang Tao Li; Ying Bin Liu; Xiu Jun Cai; Yi Ping Mou; Xue Dong Feng; Jian Wei Wang; Bin Xu; Hao Ran Qian; De Fei Hong; Xin Bao Wang; He Qing Fang; Li Ping Cao; Li Chen; Chen Hong Peng; Fu Bao Liu; Jian Feng Xue Journal: J Gastrointest Surg Date: 2006-03 Impact factor: 3.452
Authors: Sung Uk Lee; Sang Min Yoon; Jason Chia-Hsien Cheng; Tae Hyun Kim; Bo Hyun Kim; Jin-Hong Park; Jinhong Jung; Chiao-Ling Tsai; Yun Chiang; Joong-Won Park Journal: Front Oncol Date: 2021-02-26 Impact factor: 6.244